Eagle Pharmaceuticals Inc.
12/02/2024 | Press release | Distributed by Public on 12/02/2024 15:17
Corporate Action Form 8 K
Item 1.01 Entry into a Material Definitive Agreement.
The information set forth under "Item 3.03 Material Modification to Rights of Security Holders" of this Current Report on Form 8-K is incorporated into this Item 1.01 by reference.